Capricor Therapeutics (CAPR) Assets (2010 - 2026)
Capricor Therapeutics (CAPR) posted quarterly Assets of $326.3 million for Q1 2026, up 112.19% year-over-year from $153.8 million in Q1 2025, and down 8.33% quarter-over-quarter from $355.9 million in Q4 2025.
Capricor Therapeutics (CAPR) Assets (2010 - 2026) Analysis & Trends
Capricor Therapeutics' Assets history runs 17 years deep, the most recent figure standing at $326.3 million for Q1 2026.
- In Q1 2026, Assets rose 112.19% year-over-year to $326.3 million; the TTM figure through Mar 2026 stood at $326.3 million (up 112.19% YoY), while the FY2025 annual figure was $355.9 million, up 108.79% from the prior year.
- Assets for Q1 2026 stood at $326.3 million, down from $355.9 million in the prior quarter.
- The five-year high for Assets was $355.9 million in Q4 2025, with the low at $37.2 million in Q3 2023.
- The 5-year median for Assets is $58.7 million (2023), against an average of $110.0 million.
- The sharpest annual moves came in 2023 and 2025: Assets plunged 31.11% in 2023, then surged 248.95% in 2025.
- Capricor Therapeutics' Assets stood at $50.1 million in 2022, then increased by 17.25% to $58.7 million in 2023, then surged by 190.26% to $170.5 million in 2024, then soared by 108.79% to $355.9 million in 2025, then declined by 8.33% to $326.3 million in 2026.
- Business Quant data shows CAPR's Assets at $326.3 million in Q1 2026, $355.9 million in Q4 2025, and $126.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Capricor Therapeutics | 383.47 Mn | 383.47 Mn | - | 326.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 326.28 Mn |
| Dec 31, 2025 | 355.95 Mn |
| Sep 30, 2025 | 126.44 Mn |
| Jun 30, 2025 | 133.57 Mn |
| Mar 31, 2025 | 153.77 Mn |
| Dec 31, 2024 | 170.48 Mn |
| Sep 30, 2024 | 92.95 Mn |
| Jun 30, 2024 | 38.28 Mn |
| Mar 31, 2024 | 49.44 Mn |
| Dec 31, 2023 | 58.73 Mn |
| Sep 30, 2023 | 37.15 Mn |
| Jun 30, 2023 | 46.01 Mn |
| Mar 31, 2023 | 53.86 Mn |
| Dec 31, 2022 | 50.09 Mn |
| Sep 30, 2022 | 53.93 Mn |
| Jun 30, 2022 | 58.07 Mn |
| Mar 31, 2022 | 64.92 Mn |
| Dec 31, 2021 | 41.33 Mn |
| Sep 30, 2021 | 43.10 Mn |
| Jun 30, 2021 | 39.93 Mn |